Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

IBM Buys AlchemyAPI to Boost Watson Computing Unit

AlchemyAPI’s software collects and analyzes unstructured text and data.

IBM

IBM said on Wednesday it had acquired AlchemyAPI, a fast-growing startup selling software that collects and analyzes unstructured text and data in ways big enterprises, website publishers and advertisers find useful.

The purchase is designed to boost IBM’s push into more human-like computing services, based around its Watson technology, which can sift huge amounts of data, learn from the results and respond to spoken questions.

IBM is trying to build a big business around Watson, which came to prominence in 2011 when it beat two previous champions on the U.S. quiz show “Jeopardy.” IBM gives developers access to Watson so they can use the technology in their own applications, but it has only just started to filter down to mainstream use.

AlchemyAPI already has about 40,000 developers building tools using its technology, which would give IBM access to a much bigger, ready-made user base.

“They (AlchemyAPI) bring a very substantial development community and following,” said Steve Gold, vice president of IBM’s Watson group. “Plus, they have a very talented group of technologists.”

AlchemyAPI, founded in 2005 and based in Denver, has 18 full-time employees. Its customers include publishing company Hearst and image agency Shutterstock. IBM did not disclose the purchase price.

The startup’s software gathers data from a wide range of sources, from Twitter posts and news stories to website images and text messages, sorts the data, learns to differentiate between them, and allows users to see connections that would take much longer to establish using more standard computing methods.

The software, which learns as it goes, enables users to group together disparate information on a certain topic or event and find related articles or information sources, and it helps advertisers target online ads better.

With the addition of AlchemyAPI’s technology, Gold said IBM sees opportunities for Watson in many fields such as health care, law and insurance, or wherever there are large volumes of unstructured data to be analyzed.

AlchemyAPI is IBM’s second acquisition in the field after it bought artificial intelligence startup Cognea last year, which pioneered virtual assistant apps for smartphones.

(Reporting by Bill Rigby; Editing by Ken Wills)

This article originally appeared on Recode.net.

See More:

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh